Avacta Appoints Therapeutics Chief Development Officer
Avacta has appointed Neil Bell, a highly experienced pharmaceutical and [...]
Avacta has appointed Neil Bell, a highly experienced pharmaceutical and [...]
TrueBinding signs multi-product commercial-use license to develop stable, antibody-expressing cell [...]
Collaboration to develop stem cell therapies for COVID-19 and future [...]
Professor Gillian Griffiths, Dr John Haurum, Dr Jessica Strid and [...]
Avacta to begin clinical validation of the high throughput COVID-19 [...]
· Partnership awarded Innovate UK Knowledge Transfer Partnership grant · Dr. John McGrath [...]
Further milestone paves the way for production of novel gene [...]
Partnership to evaluate the use of Affimer reagents to detect [...]
Spirea, a spin-out from the University of Cambridge, has developed [...]
London and Oxford, UK, 09 July 2020: Today, LGC announced [...]